Effect of various treatment regimens on cancer cell viability. by Mohammad R. Nikmaneshi (16185668)

Subjects:

Themes, sub-themes and theoretical domains framework domains. by Joshua Brown (669431)

Subjects:

Phenotype characterization, distribution, and survival. by Annika Weidenhammer (21433547)

Subjects:

Fig 9 - by Mohammad R. Nikmaneshi (16185668)

Subjects:

Mtb binds to Lipobiotin-functionalized magnetic beads (LMBs). by Julia Hansen (3907219)

Subjects:

Data depicted in Fig 1. by Julia Hansen (3907219)

Subjects:

Contextual considerations for GVRO implementation by CFIR domain and construct. by Veronica A. Pear (10325814)

Subjects:

Key informant characteristics. by Veronica A. Pear (10325814)

Subjects:

Data depicted in Fig 5. by Julia Hansen (3907219)

Subjects:

Trajectories of GDMT up-titration limiting factors over a period of 1 year during up-titration. by Annika Weidenhammer (21433547)

Subjects:

The effect of LMB assay on qPCR-based detection of Mtb in saliva from TB patients and healthy subjects (cohort #1). by Julia Hansen (3907219)

Subjects:

Spatial maps of interstitial fluid pressure (IFP, top panels) and anti-cancer drug distribution in the tumor and surrounding tissue (bottom panels). by Mohammad R. Nikmaneshi (16185668)

Subjects:

Baseline characteristics of HFrEF patients grouped according to the presence or absence of factors limiting GDMT up-titration. by Annika Weidenhammer (21433547)

Subjects:

Data depicted in Fig 4. by Julia Hansen (3907219)

Subjects:

Use and dosage of HF therapy at baseline, 6 months, and 1 year depending on GDMT up-titration limiting factors. by Annika Weidenhammer (21433547)

Subjects:

Schematic illustration of the Lipobiotin magnetic bead assay (LMB assay). by Julia Hansen (3907219)

Subjects:

Dose schedules of anti-cancer and anti-angiogenesis drugs. by Mohammad R. Nikmaneshi (16185668)

Subjects:

Characteristics of clinicians participating in interviews on the fan for breathlessness management (N = 12). by Joshua Brown (669431)

Subjects:

Distribution and outcome of GDMT up-titration limiting factors. by Annika Weidenhammer (21433547)

Subjects:

Factors limiting GDMT up-titration of HF drugs in HFrEF. by Annika Weidenhammer (21433547)

Subjects: